- Home
- HUBC vs IGC Comparison
HUBC vs IGC Comparison
Compare HUBC & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- IGC
- Stock Information
- Founded
- HUBC 2017
- IGC 2005
- Country
- HUBC Israel
- IGC United States
- Employees
- HUBC N/A
- IGC N/A
- Industry
- HUBC
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- HUBC
- IGC Health Care
- Exchange
- HUBC Nasdaq
- IGC Nasdaq
- Market Cap
- HUBC 32.0M
- IGC 33.8M
- IPO Year
- HUBC N/A
- IGC N/A
- Fundamental
- Price
- HUBC $0.96
- IGC $0.32
- Analyst Decision
- HUBC
- IGC Strong Buy
- Analyst Count
- HUBC 0
- IGC 2
- Target Price
- HUBC N/A
- IGC $4.00
- AVG Volume (30 Days)
- HUBC 395.4K
- IGC 703.5K
- Earning Date
- HUBC 05-01-2026
- IGC 11-17-2025
- Dividend Yield
- HUBC N/A
- IGC N/A
- EPS Growth
- HUBC N/A
- IGC N/A
- EPS
- HUBC N/A
- IGC N/A
- Revenue
- HUBC $29,562,000.00
- IGC $1,106,000.00
- Revenue This Year
- HUBC N/A
- IGC $3.54
- Revenue Next Year
- HUBC N/A
- IGC $15.12
- P/E Ratio
- HUBC N/A
- IGC N/A
- Revenue Growth
- HUBC N/A
- IGC N/A
- 52 Week Low
- HUBC $0.89
- IGC $0.25
- 52 Week High
- HUBC $14.00
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- HUBC 30.51
- IGC 26.45
- Support Level
- HUBC $0.89
- IGC $0.31
- Resistance Level
- HUBC $1.04
- IGC $0.37
- Average True Range (ATR)
- HUBC 0.13
- IGC 0.02
- MACD
- HUBC -0.02
- IGC -0.01
- Stochastic Oscillator
- HUBC 15.65
- IGC 6.16
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.